Repeat Kidney Biopsy in Suspected Relapse of ANCA-Associated Vasculitis: A Case of De Novo IgAN

Introduction: Microscopic polyangiitis is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Although relapse during maintenance therapy is relatively common, the coexistence or subsequent development of other glomerular diseases, such as IgA nephropathy, is exceedingly rare. Case Description: An 81-year-old woman was diagnosed with renal-limited vasculitis 9 years earlier. At initial presentation, she had elevated myeloperoxidase (MPO)-ANCA levels and crescentic glomerulonephritis. Remission was achieved with prednisolone induction therapy. Serum creatinine remained stable at approximately 0.9 mg/dL, and remission was maintained with low-dose prednisolone. She subsequently experienced two episodes of MPO-ANCA elevation accompanied by microscopic hematuria, both of which responded to an increased dose of prednisolone. At the current presentation, she had proteinuria (3.44 g/gCr), microscopic hematuria (20–29/HPF), and elevated serum creatinine (1.28 mg/dL), raising suspicion of a relapse of AAV presenting as rapidly progressive glomerulonephritis. The prednisolone dose was increased, and avacopan and rituximab were initiated. However, a repeat kidney biopsy revealed de novo IgA nephropathy. Avacopan was discontinued, prednisolone was tapered, and an angiotensin II receptor blocker was introduced. Thereafter, the patient’s proteinuria improved markedly and kidney function remained stable. Discussion: This case illustrates the de novo development of IgA nephropathy during long-term maintenance therapy for microscopic polyangiitis. It underscores the importance of considering alternative or coexisting glomerular pathologies and highlights the critical role of repeat kidney biopsy in establishing an accurate diagnosis when clinical deterioration occurs in a patient with established AAV. Given the rarity of concurrent AAV and IgA nephropathy, further collection and analysis of similar cases are warranted to elucidate their potential association.

Authors

Institutions

Publication Details

Journal
Journal of the American Society of Nephrology
Published
2025-10-01
DOI
https://doi.org/10.1681/asn.20253gg27hxs
Primary Topic
Vasculitis and related conditions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Repeat Kidney Biopsy in Suspected Relapse of ANCA-Associated Vasculitis: A Case of De Novo IgAN

Takaaki Kosugi, Kazuhiko Tsuruya, Masaru Matsui, Riri Furuyama et al.
Journal of the American Society of Nephrology
Vasculitis and related conditions
article

Repeat Kidney Biopsy in Suspected Relapse of ANCA-Associated Vasculitis: A Case of De Novo IgAN

Takaaki Kosugi, Kazuhiko Tsuruya, Masaru Matsui, Riri Furuyama, Masahiro Eriguchi, Ken‐ichi Samejima, Kaori Tanabe, Shunsuke Kitamura, Seina Iwami
article en

Abstract

Introduction: Microscopic polyangiitis is a subtype of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Although relapse during maintenance therapy is relatively common, the coexistence or subsequent development of other glomerular diseases, such as IgA nephropathy, is exceedingly rare. Case Description: An 81-year-old woman was diagnosed with renal-limited vasculitis 9 years earlier. At initial presentation, she had elevated myeloperoxidase (MPO)-ANCA levels and crescentic glomerulonephritis. Remission was achieved with prednisolone induction therapy. Serum creatinine remained stable at approximately 0.9 mg/dL, and remission was maintained with low-dose prednisolone. She subsequently experienced two episodes of MPO-ANCA elevation accompanied by microscopic hematuria, both of which responded to an increased dose of prednisolone. At the current presentation, she had proteinuria (3.44 g/gCr), microscopic hematuria (20–29/HPF), and elevated serum creatinine (1.28 mg/dL), raising suspicion of a relapse of AAV presenting as rapidly progressive glomerulonephritis. The prednisolone dose was increased, and avacopan and rituximab were initiated. However, a repeat kidney biopsy revealed de novo IgA nephropathy. Avacopan was discontinued, prednisolone was tapered, and an angiotensin II receptor blocker was introduced. Thereafter, the patient’s proteinuria improved markedly and kidney function remained stable. Discussion: This case illustrates the de novo development of IgA nephropathy during long-term maintenance therapy for microscopic polyangiitis. It underscores the importance of considering alternative or coexisting glomerular pathologies and highlights the critical role of repeat kidney biopsy in establishing an accurate diagnosis when clinical deterioration occurs in a patient with established AAV. Given the rarity of concurrent AAV and IgA nephropathy, further collection and analysis of similar cases are warranted to elucidate their potential association.

Journal of the American Society of NephrologyVol. 36(10S)
Nara Medical University (JP)
Openalex Percentile: Top 56%
Vasculitis and related conditions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.